177 related articles for article (PubMed ID: 1389697)
1. Tumor antigen phenotype, biologic staging, and prognosis in head and neck squamous carcinoma.
Wolf GT; Carey TE
J Natl Cancer Inst Monogr; 1992; (13):67-74. PubMed ID: 1389697
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of the A9 antigen/alpha 6 beta 4 integrin in head and neck cancer.
Van Waes C; Carey TE
Otolaryngol Clin North Am; 1992 Oct; 25(5):1117-39. PubMed ID: 1383908
[TBL] [Abstract][Full Text] [Related]
3. The A9 antigen associated with aggressive human squamous carcinoma is structurally and functionally similar to the newly defined integrin alpha 6 beta 4.
Van Waes C; Kozarsky KF; Warren AB; Kidd L; Paugh D; Liebert M; Carey TE
Cancer Res; 1991 May; 51(9):2395-402. PubMed ID: 1750876
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of the alpha v beta 6 integrin in cervical squamous cell carcinoma is a prognostic factor for decreased survival.
Hazelbag S; Kenter GG; Gorter A; Dreef EJ; Koopman LA; Violette SM; Weinreb PH; Fleuren GJ
J Pathol; 2007 Jul; 212(3):316-24. PubMed ID: 17503414
[TBL] [Abstract][Full Text] [Related]
5. Expression of A9 antigen and loss of blood group antigens as determinants of survival in patients with head and neck squamous carcinoma.
Carey TE; Wolf GT; Hsu S; Poore J; Peterson K; McClatchey KD
Otolaryngol Head Neck Surg; 1987 Mar; 96(3):221-30. PubMed ID: 3108804
[TBL] [Abstract][Full Text] [Related]
6. Altered antigen expression predicts outcome in squamous cell carcinoma of the head and neck.
Wolf GT; Carey TE; Schmaltz SP; McClatchey KD; Poore J; Glaser L; Hayashida DJ; Hsu S
J Natl Cancer Inst; 1990 Oct; 82(19):1566-72. PubMed ID: 2119437
[TBL] [Abstract][Full Text] [Related]
7. Integrin beta 4 expression in the neoplastic progression of cervical epithelium.
Carico E; French D; Bucci B; Falcioni R; Vecchione A; Mariani-Costantini R
Gynecol Oncol; 1993 Apr; 49(1):61-6. PubMed ID: 7683305
[TBL] [Abstract][Full Text] [Related]
8. An immunological outcome predictive score for head and neck carcinoma patients.
Kaffenberger W; Hölzer-Müller L; Auberger T; Clasen BP; Hohlmeier G; van Beuningen D
Strahlenther Onkol; 1995 Aug; 171(8):444-53. PubMed ID: 7652667
[TBL] [Abstract][Full Text] [Related]
9. [The effect of the microenvironment of head and neck cancers on tumor progression].
Lukits J
Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327
[TBL] [Abstract][Full Text] [Related]
10. SCC-RIA in the diagnosis of squamous cell carcinoma of the head and neck.
Eibling DE; Johnson JT; Wagner RL; Su S
Laryngoscope; 1989 Feb; 99(2):117-24. PubMed ID: 2913421
[TBL] [Abstract][Full Text] [Related]
11. [Tumor markers in patients with head-neck carcinomas].
Walther EK; Dahlmann N; Gorgulla HT
Laryngorhinootologie; 1990 May; 69(5):271-4. PubMed ID: 2354022
[TBL] [Abstract][Full Text] [Related]
12. The p16 (CDKN2a/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: a promoter methylation and protein expression study in 100 cases.
Ai L; Stephenson KK; Ling W; Zuo C; Mukunyadzi P; Suen JY; Hanna E; Fan CY
Mod Pathol; 2003 Sep; 16(9):944-50. PubMed ID: 13679459
[TBL] [Abstract][Full Text] [Related]
13. Increase in suprabasilar integrin adhesion molecule expression in human epidermal neoplasms accompanies increased proliferation occurring with immortalization and tumor progression.
Van Waes C; Surh DM; Chen Z; Kirby M; Rhim JS; Brager R; Sessions RB; Poore J; Wolf GT; Carey TE
Cancer Res; 1995 Nov; 55(22):5434-44. PubMed ID: 7585613
[TBL] [Abstract][Full Text] [Related]
14. Gamma-delta T-cells in patients with squamous cell carcinoma of the head and neck.
Bas M; Bier H; Schirlau K; Friebe-Hoffmann U; Scheckenbach K; Balz V; Whiteside TL; Hoffmann TK
Oral Oncol; 2006 Aug; 42(7):691-7. PubMed ID: 16527515
[TBL] [Abstract][Full Text] [Related]
15. [The expression of zeta-chain of the T cell receptor as prognostic marker for patients with head and neck cancer].
Müller D; Lang S; Roskrow M; Wollenberg B
Laryngorhinootologie; 2002 Jul; 81(7):516-20. PubMed ID: 12173063
[TBL] [Abstract][Full Text] [Related]
16. Topoisomerase II alpha expression in squamous cell carcinomas of the head and neck.
Stathopoulos GP; Kapranos N; Manolopoulos L; Papadimitriou C; Adamopoulos G
Anticancer Res; 2000; 20(1A):177-82. PubMed ID: 10769652
[TBL] [Abstract][Full Text] [Related]
17. c-erbB-2 oncoprotein is overexpressed in poorly vascularised squamous cell carcinomas of the head and neck, but is not associated with response to cytotoxic therapy or survival.
Giatromanolaki A; Koukourakis MI; Sivridis E; Fountzilas G
Anticancer Res; 2000; 20(2A):997-1004. PubMed ID: 10810387
[TBL] [Abstract][Full Text] [Related]
18. [Clinical evaluation of tumor markers in head and neck squamous cell carcinomas].
Yoneda K; Hirota J; Yamamoto T; Ueta E; Osaki T
Gan No Rinsho; 1990 Mar; 36(4):458-64. PubMed ID: 2181163
[TBL] [Abstract][Full Text] [Related]
19. Human leukocyte antigen class I allelic and haplotype loss in squamous cell carcinoma of the head and neck: clinical and immunogenetic consequences.
Grandis JR; Falkner DM; Melhem MF; Gooding WE; Drenning SD; Morel PA
Clin Cancer Res; 2000 Jul; 6(7):2794-802. PubMed ID: 10914726
[TBL] [Abstract][Full Text] [Related]
20. Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients.
Nathan CO; Amirghahri N; Rice C; Abreo FW; Shi R; Stucker FJ
Laryngoscope; 2002 Dec; 112(12):2129-40. PubMed ID: 12461330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
